Chart calendar Charles River Laboratories International, Inc.

823.whOlqzD6ZjIWGTn8q2lZq_MBVzhswVSquH6OHD6hQwM.gWGXzUS2DWA7eH_R7R0b2MJlBU0WqhHmwEvGeAqYKU6XY-T5XrJUYVt4Vg~85cab5d39f91bd9615076d9a8e508fb3

Upcoming events on Charles River Laboratories International, Inc.

24/09/2026

Analyst/Investor Day

06:30 pm

Past events on Charles River Laboratories International, Inc.

05/08/2026

Earnings presentation

06:30 pm
05/08/2026

Earnings release - Q2 2026

07/05/2026

Earnings presentation

06:00 pm
07/05/2026

Earnings release - Q1 2026

05/05/2026

Annual General Meeting

05:30 pm
18/02/2026

Earnings release - Q4 2025

18/02/2026

Earnings presentation

07:00 pm
05/11/2025

Earnings presentation

07:30 pm
05/11/2025

Earnings release - Q3 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
4 129
4 107
0.54%
4 050
4 031
0.47%
4 015
4 006
0.23%

3 911


4 001


4 208

EBITDA
Million USD
Released
Forecast
Spread
1 013
1 017
-0.4%
996
998
-0.19%
972
966
0.56%

1 008


1 093


1 174

EBIT
Million USD
Released
Forecast
Spread
839
842
-0.35%
806
802
0.46%
794
794
0.01%

821


912


1 001

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
581
513
13.41%
93,1
401
-76.8%
-99,5
312
-131.9%

285


535


613

Net income
Million USD
Released
Forecast
Spread
475
387
22.66%
10,3
301
-96.58%
-144
215
-167.17%

162


428


471

EPS
USD
Released
Forecast
Spread
9,22
7,49
23.07%
0,20
5,83
-96.57%
-2,91
4,19
-169.42%

3,74


9,35


10,4

Announcement Date14/02/2419/02/2518/02/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4 2028 Q1 2028 Q2
Net sales
Million USD
Released
Forecast
Spread
1 003
984
1.92%
984
942
4.48%
1 032
990
4.3%
1 005
991
1.42%
994
987
0.73%
996
979
1.67%
1 004
977
2.75%

959


953


974


1 008


1 008


1 004


1 014


1 044

EBITDA
Million USD
Released
Forecast
Spread
248
245
1.35%
232
216
7.35%
272
248
10.07%
243
231
4.98%
225
225
-0.14%
204
199
2.28%
245
248
-1.09%

263


282


252


271


276


284


262


279

EBIT
Million USD
Released
Forecast
Spread
200
196
1.71%
188
169
11.54%
228
194
17.86%
198
186
6.32%
180
180
0.01%
163
153
6.5%
206
203
1.45%

217


234


199


216


229


235


213


228

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-217
66,0
-428.29%










































Net income
Million USD
Released
Forecast
Spread
-216
47,5
-553.65%
25,5
45,3
-43.75%



54,4
58,7
-7.21%
-277
68,3
-505.08%
-14,8
35,8
-141.47%
-1,48
91,9
-101.61%

84,0


93,8


104


121


126


139


101


117

EPS
USD
Released
Forecast
Spread
-4,22
1,19
-453.88%
0,50
0,97
-48.45%
1,06
1,38
-23.19%
1,10
1,45
-23.96%
-5,62
1,35
-515.27%
-0,30
0,91
-133.15%
-0,03
2,03
-101.48%

2,09


2,43


2,27


2,68


2,74


3,01


2,18


2,52

Announcement Date19/02/2507/05/2506/08/2505/11/2518/02/2607/05/2605/08/26--------
13/08/2026

Earnings presentation

05:30 pm
13/08/2026

Earnings release - Q2 2026

13/08/2026

Earnings release - Q2 2026

13/08/2026

Earnings release - Q2 2026

13/08/2026

Earnings release - Q2 2026

13/08/2026

Earnings presentation

06:30 pm
14/08/2026

Earnings presentation

06:00 pm
14/08/2026

Board of Directors Meeting

14/08/2026

Earnings release - Q1 2027

14/08/2026

Earnings release - Q2 2026

P

Past sector events for Charles River Laboratories International, Inc.

Today

Information meeting

05:30 pm
12/08/2026

Earnings release - Q2 2026

12/08/2026

Earnings presentation

02:00 am
12/08/2026

Earnings presentation

02:00 am
12/08/2026

Earnings release - Q2 2026

Today

Significant Split/Dividend

09:30 am
11/08/2026

Présentation aux Actionnaires / Analystes

06:30 pm
11/08/2026

Extraordinary General Meeting

06:30 pm
11/08/2026

Earnings presentation

10/08/2026

Information meeting

05:00 pm

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRL Stock
  4. Calendar Charles River Laboratories International, Inc.